Management of Staphylococcus aureus infections

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Staphylococcus aureus infections present significant challenges due to high incidence, morbidity, and rising antimicrobial resistance.
• Vancomycin-resistant strains and community-acquired methicillin-resistant S. aureus (CA-MRSA) infections are increasingly recognized, posing substantial risks.
• Suboptimal adherence to Centers for Disease Control and Prevention (CDC) recommended precautions, particularly handwashing, exacerbates the problem.

Purpose of the Study:

• To highlight the growing concern of Staphylococcus aureus infections for family physicians.
• To discuss the implications of antimicrobial resistance, including vancomycin resistance and CA-MRSA.
• To review available treatments and the importance of preventive measures.

Main Methods:

• Literature review and synthesis of current data on S. aureus infections.
• Analysis of trends in incidence, morbidity, and antimicrobial resistance.
• Discussion of clinical manifestations and treatment options.

Main Results:

• S. aureus is a common cause of diverse infections, including skin, soft-tissue, and invasive conditions like bacteremia and endocarditis.
• Antimicrobial resistance, notably vancomycin resistance and CA-MRSA, is a significant and increasing issue.
• New antimicrobial agents like daptomycin and linezolid offer treatment options for complex infections.

Conclusions:

• Staphylococcus aureus infections, especially resistant strains, require urgent attention from healthcare providers.
• Effective management necessitates awareness of resistance patterns, appropriate use of new antimicrobial agents, and improved adherence to infection control practices.
• Enhanced preventive strategies, including rigorous hand hygiene, are crucial to mitigate the spread and impact of S. aureus infections.